Press releases
- Revvity to Present at Goldman Sachs Global Healthcare Conference
- Revvity Announces Financial Results for the First Quarter of 2024
- Revvity Board Declares Quarterly Dividend
- Revvity to Present at BofA Securities 2024 Health Care Conference
- Revvity Unveils a New Era of Automated Tuberculosis Testing
- Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
- Revvity To Hold Earnings Call on Monday, April 29, 2024
- Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
- Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
- Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
More ▼
Key statistics
On Friday, Revvity Inc (PKN:FRA) closed at 99.62, -16.04% below its 52-week high of 118.65, set on Jul 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 98.98 |
---|---|
High | 99.62 |
Low | 98.98 |
Bid | 99.74 |
Offer | 101.75 |
Previous close | 96.14 |
Average volume | 132.00 |
---|---|
Shares outstanding | 123.39m |
Free float | 123.03m |
P/E (TTM) | 73.99 |
Market cap | 13.48bn USD |
EPS (TTM) | 1.48 USD |
Annual div (ADY) | 0.2582 EUR |
---|---|
Annual div yield (ADY) | 0.26% |
Div ex-date | Apr 18 2024 |
Div pay-date | May 10 2024 |
Next div ex-date | Jul 19 2024 |
Next div pay-date | Aug 09 2024 |
Data delayed at least 15 minutes, as of May 31 2024 14:43 BST.
More ▼